These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22083180)

  • 1. [Risk management in ambulatory anti-cancer therapy, focusing on nausea and vomiting].
    Hatake K
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1758-60. PubMed ID: 22083180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessment of chemotherapy-induced nausea and vomiting(CINV)using MASCC antiemesis tool].
    Yamaguchi M; Ogawa T; Watanabe M; Anami S; Kamigaki S; Nishikawa N; Ono T; Furukawa H
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1691-6. PubMed ID: 19838029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpharmacologic management of chemotherapy-induced nausea and vomiting.
    King CR
    Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):41-8. PubMed ID: 9282380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral treatment for the anticipatory nausea and vomiting induced by cancer chemotherapy.
    Morrow GR; Morrell C
    N Engl J Med; 1982 Dec; 307(24):1476-80. PubMed ID: 6128673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nausea and vomiting].
    Fujii M
    Nihon Rinsho; 2003 Jun; 61(6):954-8. PubMed ID: 12806942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study of a relaxation technique for management of nausea and vomiting in patients receiving cancer chemotherapy.
    Campos de Carvalho E; Martins FT; dos Santos CB
    Cancer Nurs; 2007; 30(2):163-7. PubMed ID: 17413783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced nausea and vomiting: clinician and patient perspectives.
    Schwartzberg LS
    J Support Oncol; 2007 Feb; 5(2 Suppl 1):5-12. PubMed ID: 17366928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
    Chawla SP; Grunberg SM; Gralla RJ; Hesketh PJ; Rittenberg C; Elmer ME; Schmidt C; Taylor A; Carides AD; Evans JK; Horgan KJ
    Cancer; 2003 May; 97(9):2290-300. PubMed ID: 12712486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral treatment of chemotherapy-induced nausea and vomiting.
    Morrow GR; Hickok JT
    Oncology (Williston Park); 1993 Dec; 7(12):83-9; discussion 93-4, 97. PubMed ID: 8292509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Croatian guideliness for prevention of chemotherapy induced nausea and vomiting].
    Tomek R; Vrdoljak E; Vrbanec D; Nemet D; Matković V; Plestina S; Gugić D; Dintinjana RD; Bolanca A; Samarzija M; Petković M
    Lijec Vjesn; 2009; 131(3-4):49-53. PubMed ID: 19514248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chemotherapy-associated nausea and vomiting on patients' functional status and on costs: survey of five Canadian centres.
    O'Brien BJ; Rusthoven J; Rocchi A; Latreille J; Fine S; Vandenberg T; Laberge F
    CMAJ; 1993 Aug; 149(3):296-302. PubMed ID: 8339175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
    Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
    Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprepitant--where do we stand in the control of chemotherapy-induced nausea and vomiting?
    Sarcev T; Secen N; Zaric B; Milovancev A
    J BUON; 2008; 13(3):333-9. PubMed ID: 18979546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
    de Wit R; Herrstedt J; Rapoport B; Carides AD; Guoguang-Ma J; Elmer M; Schmidt C; Evans JK; Horgan KJ
    Eur J Cancer; 2004 Feb; 40(3):403-10. PubMed ID: 14746859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of aprepitant in management of chemotherapy-induced nausea and vomiting.
    Osorio-Sanchez JA; Karapetis C; Koczwara B
    Intern Med J; 2007 Apr; 37(4):247-50. PubMed ID: 17388865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhalation marijuana as an antiemetic for cancer chemotherapy.
    Vinciguerra V; Moore T; Brennan E
    N Y State J Med; 1988 Oct; 88(10):525-7. PubMed ID: 3231372
    [No Abstract]   [Full Text] [Related]  

  • 18. Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial.
    Dibble SL; Luce J; Cooper BA; Israel J; Cohen M; Nussey B; Rugo H
    Oncol Nurs Forum; 2007 Jul; 34(4):813-20. PubMed ID: 17723973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aprepitant for chemotherapy-induced nausea and vomiting.
    Flemm LA
    Clin J Oncol Nurs; 2004 Jun; 8(3):303-6. PubMed ID: 15208824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Casopitant: a new warrior in the antiemetic crusade.
    Khojasteh A; Khojasteh A; Thornburg BG; Maher KR
    Expert Opin Pharmacother; 2009 Jun; 10(8):1367-76. PubMed ID: 19445564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.